ACTN2 as A Drug Target and Biomarker for Diseases (G88)

Target Name: ACTN2

NCBI ID: G88

ACTN2

ACTN2 as A Drug Target and Biomarker for Diseases

Actinin alpha 2 (ACTN2) is a protein that is expressed in various tissues throughout the body, including the heart, lungs, kidneys, and liver. It is a key component of the cytoskeleton, which is the structure that gives cells their shape and supports their mechanical forces. ACTN2 is also involved in cell signaling, and has been linked to a number of diseases, including cancer, cardiovascular disease, and neurodegenerative disorders.

Drug Targeting

ACTN2 is a drug target that has been identified as a potential therapeutic target for a number of diseases. One of the main reasons for its potential as a drug target is its involvement in cell signaling. ACTN2 is a protein that is involved in the regulation of cell signaling pathways, and it has been linked to the development and progression of a number of diseases.

For example, ACTN2 has been linked to the development of cancer. Studies have shown that high levels of ACTN2 are associated with the development of cancer, and that inhibiting ACTN2 signaling can be an effective way to prevent cancer growth. Additionally, ACTN2 has been linked to the development of cardiovascular disease. Studies have shown that ACTN2 is involved in the regulation of blood pressure, and that high levels of ACTN2 are associated with an increased risk of cardiovascular disease.

Another potential drug target for ACTN2 is its role in neurodegenerative disorders. Studies have shown that ACTN2 is involved in the regulation of neurotransmitter signaling in the brain, and that abnormal levels of ACTN2 have been linked to the development of neurodegenerative disorders. Therefore, inhibiting ACTN2 signaling may be an effective way to treat neurodegenerative disorders.

Biomarker

ACTN2 is also a potential biomarker for a number of diseases. For example, ACTN2 levels have been shown to be elevated in a number of diseases, including cancer, cardiovascular disease, and neurodegenerative disorders. Additionally, studies have shown that ACTN2 is involved in the regulation of cell signaling pathways, which may be an effective way to diagnose and monitor these diseases.

Conclusion

In conclusion, ACTN2 is a protein that is involved in a number of important cellular processes in the body, including cell signaling and the regulation of the cytoskeleton. It is a potential drug target for a number of diseases, including cancer, cardiovascular disease, and neurodegenerative disorders. Additionally, ACTN2 is also a potential biomarker for these diseases. Further research is needed to fully understand the role of ACTN2 in these diseases and to develop effective treatments.

Protein Name: Actinin Alpha 2

Functions: F-actin cross-linking protein which is thought to anchor actin to a variety of intracellular structures. This is a bundling protein

The "ACTN2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ACTN2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets